FDA approves expanded indications for Ilaris for three rare diseases - FDA Press Releases

The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients:

from Food and Drug Administration--Press Releases http://ift.tt/2cNz4AJ
via IFTTT